UCB (UCBJF) News Today $152.50 0.00 (0.00%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisAnalyst ForecastsChartFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period July 26 at 6:44 PM | finance.yahoo.comWaters Corporation (WAT)July 26 at 6:44 PM | seekingalpha.comUCB SA (UCBJF) Q2 2024 Earnings Call TranscriptApril 25, 2024 | msn.comUCB SA goes ex dividend tomorrowApril 24, 2024 | seekingalpha.comArtisan Global Equity Fund Q1 2024 CommentaryApril 24, 2024 | seekingalpha.comArtisan International Fund Q1 2024 CommentaryMarch 22, 2024 | finance.yahoo.comUCB Convening Notice to the General Meeting of the Shareholders 2024March 7, 2024 | realmoney.thestreet.comUCB price target raised by EUR 13 at BarclaysFebruary 28, 2024 | msn.comUCB SA reports FY resultsFebruary 10, 2024 | marketwatch.comStocks A-ZFebruary 4, 2024 | msn.comInvestors growing more bullish on SMID cap biotech stocksNovember 14, 2023 | msn.comUCB launches newly approved psoriasis drug Bimzelx in USNovember 11, 2023 | finance.yahoo.comPost Hoc Analysis Showed CIMZIA® (Certolizumab Pegol) Resulted in Meaningful Efficacy for RA Patients with High Levels of Rheumatoid Factor (RF)November 10, 2023 | finance.yahoo.comUCB Presents New Five-Year Data on BIMZELX® (bimekizumab-bkzx) in Ankylosing Spondylitis at ACR Convergence 2023October 18, 2023 | finance.yahoo.comBIMZELX® Approved by the U.S. FDA for the Treatment of Adults with Moderate-to-Severe Plaque PsoriasisOctober 18, 2023 | finance.yahoo.comUCB announces U.S. FDA approval of ZILBRYSQ® (zilucoplan) for the treatment of adults with generalized myasthenia gravisOctober 13, 2023 | finance.yahoo.comUCB Reinforces Commitment to Advancing Care in Hidradenitis Suppurativa with Six Abstracts at SHSA 2023October 12, 2023 | finance.yahoo.comPhase 3 Data Analysis Presented at EADV 2023 Showed Bimekizumab Achieved High Thresholds of Clinical Response in Hidradenitis SuppurativaAugust 14, 2023 | marketbeat.comUCB SA (OTCMKTS:UCBJF) Receives Average Rating of "Hold" from AnalystsShares of UCB SA (OTCMKTS:UCBJF - Get Free Report) have been given a consensus rating of "Hold" by the seven brokerages that are presently covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell rating, one has given a hold rating and four have iJune 27, 2023 | finance.yahoo.comFDA Approves Rystiggo: The Only Treatment for Two Most Common Subtypes of Generalized Myasthenia Gravis in AdultsFebruary 22, 2023 | finance.yahoo.comChina Anti-Rheumatic Drug Markets Report 2022-2027 Featuring Pfizer, F. Hoffmann-La Roche, UCB S.A., Eli Lilly and Company, & AbbVie Inc.October 20, 2022 | finance.yahoo.comUCB SA (UCBJF)September 12, 2022 | marketbeat.comUCB SA (OTCMKTS:UCBJF) Given Average Recommendation of "Hold" by BrokeragesJuly 25, 2022 | marketbeat.comUCB (OTCMKTS:UCBJF) Downgraded by Jefferies Financial GroupJefferies Financial Group downgraded shares of UCB from a "buy" rating to a "hold" rating in a report on Monday.May 16, 2022 | marketbeat.comUCB SA (OTCMKTS:UCBJF) Short Interest Up 31.0% in AprilUCB SA (OTCMKTS:UCBJF - Get Rating) was the target of a significant increase in short interest in April. As of April 30th, there was short interest totalling 615,100 shares, an increase of 31.0% from the April 15th total of 469,500 shares. Based on an average daily volume of 100 shares, the short-interest ratio is presently 6,151.0 days.April 25, 2022 | finance.yahoo.comHere's Why Momentum in UCB SA (UCBJF) Should Keep goingMarch 31, 2022 | msn.comWhat Makes UCB SA (UCBJF) a Good Fit for "Trend Investing"March 25, 2022 | finanznachrichten.deUCB SA/NV - CONVENING NOTICE TO THE GENERAL MEETING OF SHAREHOLDERS 2022February 7, 2022 | seekingalpha.comBiogen signs licensing deal with Xbrane for potential biosimilar to CimziaJanuary 23, 2022 | finance.yahoo.comZGNX Jan 2022 7.000 callJanuary 21, 2022 | msn.comWhy Zogenix Flew Higher Before Leveling Off This WeekJanuary 19, 2022 | markets.businessinsider.comUCB to Buy Epilepsy-Focused Zogenix In $1.9B Deal: See The HighlightsNovember 5, 2021 | finance.yahoo.comUCB Showcases Key Rheumatology Data at ACR Convergence 2021October 20, 2021 | finance.yahoo.comUCB to license its AI technology that improves identification of Osteoporosis to ImageBiopsy LabOctober 16, 2021 | msn.comBRIEF-UCB SA Gives An Update On U.S. FDA Review Of Biologics License Application (BLA) For BimekizumabSeptember 29, 2021 | finance.yahoo.comNew Bimekizumab Two-Year Data in Moderate to Severe Plaque Psoriasis Presented at the 30th European Academy of Dermatology and Venereology CongressAugust 27, 2021 | benzinga.comWhy New Oriental Education Shares Are FallingAugust 12, 2021 | finance.yahoo.comSpectrumDNA, Inc. (SPXA) Get UCB News Delivered to You Automatically Sign up to receive the latest news and ratings for UCBJF and its competitors with MarketBeat's FREE daily newsletter. Email Address 625,000% Gain (Ad)Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here UCBJF Media Mentions By Week UCBJF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. UCBJF News Sentiment▼0.000.61▲Average Medical News Sentiment UCBJF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. UCBJF Articles This Week▼20▲UCBJF Articles Average Week Get UCB News Delivered to You Automatically Sign up to receive the latest news and ratings for UCBJF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CAPS News Today EVLO News Today GNMSF News Today GRFS News Today HYPMY News Today ISCO News Today LVTX News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:UCBJF) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredThe #1 Crypto for 2024 (3 Cent Coin)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredAlex's "Next Magnificent Seven" StocksToday Alex Green is releasing his new breakdown of AI's "Next Magnificent Seven." So please make some time ...The Oxford Club | SponsoredNEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands o...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding UCB SA Please log in to your account or sign up in order to add this asset to your watchlist. Share UCB With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.